Implanet commenced commercial launch of the JAZZ™ Braid device in the EU and U.S. following regulatory clearance in those regions.
JAZZ Braid represents improvements to the company's JAZZ spinal fusion platform. For instance, part of the band is now ultrasonically bonded to improve handling and stability. The braid is compatible with the current JAZZ instrument system.
This is the tenth successive FDA 510(k) clearance for the JAZZ product range.
Sources: Implanet; ORTHOWORLD Inc.